In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ?-catenin, a historically "undruggable" protein, in just two months. This ...

In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide ...

Scientists have visualized the detailed structure of protein clumps linked to Huntington's disease, offering critical ...

RiDYMO® has been successfully employed in various drug discovery programs, including the development of small molecule ...

When a spider is spinning its web, its silk starts out as liquid and quickly turns into a solid that is, pound for pound, ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

In an era of medical care that is increasingly aiming at more targeted medication therapies, more individual therapies and ...

Mitochondrial calcium signaling is crucial for energy metabolism and calcium homeostasis, but monitoring it accurately is ...

GEMS is designed to generate and optimize molecules for complex targets ... using Genesis’ platform for deep learning and molecular simulation. In 2022, Genentech described its targets of ...